Generic Drugs Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Generic Drugs Market
Generic Drugs Market: By Drug Class(Cardiovascular Products, Anti-Infective Drugs, Anti-Arthritis Drugs, Central Nervous System Drugs, Anti-Cancer Drugs, Respiratory Products, Others) & By Geography (Europe, Asia-Pacific, Others) - Forecast(2018 - 2023)
Report Code : HCR 0217
Updated Date: 16 May, 2018  

1. Generic Drugs – Market Overview
2. Executive Summary
3. 
Generic Drugs Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Generic Drugs – Market Forces
   4.1. Drivers
      4.1.1. cost-effectiveness of generic drugs against branded drugs
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Generic Drugs Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Generic Drugs Market, By Drug Class
   6.1. Cardiovascular Products
   6.2. Anti-Infective Drugs
   6.3. Anti-Arthritis Drugs
   6.4. Central Nervous System Drugs
   6.5. Anti-Cancer Drugs
   6.6. Respiratory Products
   6.7. Others
7. Generic Drugs Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Generic Drugs – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
   9.1. WATSON PHARMACEUTICALS, INC.
   9.2. TEVA PHARMACEUTICAL INDUSTRIES, LTD.
   9.3. SANDOZ INTERNATIONAL GMBH      
   9.4. RANBAXY LABORATORIES, LTD.
   9.5. PAR PHARMACEUTICAL, INC.  
   9.6. MYLAN INC.     
   9.7. HOSPIRA, INC.  
   9.8. DR. REDDY’S LABORATORIES, LTD.     
   9.9. APOTEX INC. 
   9.10. ACTAVIS      
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $7250
Related Reports
0px;">Scroll